BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6208091)

  • 1. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH; Koh SH; Hay DL; Cauchi MN
    Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers in the ovarian carcinoma.
    Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
    Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical localization of tumor markers in epithelial ovarian cancer.
    Casper S; van Nagell JR; Powell DF; Dubilier LD; Donaldson ES; Hanson MB; Pavlik EJ
    Am J Obstet Gynecol; 1984 May; 149(2):154-8. PubMed ID: 6202143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour markers in ovarian cancer.
    van Nagell JR
    Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fetal and placental proteins in ovarian cancer].
    Tatra G; Ludwig H
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():138-41. PubMed ID: 6163685
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum markers in malignant diseases].
    Peter HH
    Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunocytochemical localization of neuroendocrine hormones and oncofetal antigens in ovarian teratomas.
    Calame J; Bosman FT; Schaberg A; Louwerens JW
    Int J Gynecol Pathol; 1984; 3(1):92-100. PubMed ID: 6203857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated antigens in polyps and carcinoma of the human large bowel.
    Skinner JM; Whitehead R
    Cancer; 1981 Mar; 47(6):1241-5. PubMed ID: 6164469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
    Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
    Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
    Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of biochemical markers between benign and malignant ovarian cysts.
    Knight JA; Wu JT; Miya T; Knight DP
    Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological markers in gynecologic cancers. An overview.
    Dini MM; Miller M
    IMJ Ill Med J; 1984 Sep; 166(3):166-71. PubMed ID: 6208177
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on tissue-localization of various tumormarkers in ovarian tumors by immunoperoxidase method].
    Tanimura T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2344-52. PubMed ID: 2416855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
    Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
    Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic monitoring of cervical carcinoma.
    Almerigogna F; Borri P; Buzzoni P; Locatelli F; Savino L
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):164-7. PubMed ID: 6176450
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
    Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
    Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological markers in human lung carcinoma: an immunopathological study of six antigens.
    Harach HR; Skinner M; Gibbs AR
    Thorax; 1983 Dec; 38(12):937-41. PubMed ID: 6198740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour antigens associated with primary mediastinal choriocarcinoma.
    Forest JC; Talbot J; Pagé M; Loiselle JM
    Can Med Assoc J; 1977 Dec; 117(12):1386-8. PubMed ID: 73406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.